Kyowa Kirin Files Nesp in Japan for Anemia in Myelodysplastic Syndrome

April 2, 2014
Kyowa Hakko Kirin announced on March 31 that it filed on the same day for an additional indication of anemia in myelodysplastic syndrome for its long-acting erythropoiesis stimulating agent Nesp Injection Plastic Syringe (recombinant darbepoetin alfa) in Japan. Kyowa Kirin...read more